Soursop tea study for advanced blood cancer
Part of Blood & lymphatic, Cancer clinical trials.
This study tests whether drinking soursop tea can help people with advanced acute myeloid leukemia (AML) or multiple myeloma (MM) when other treatments have stopped working. It aims to see if the tea is safe and can reduce signs of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have AML or multiple myeloma that has come back or not responded to treatment, and no other treatment options are available.
- You are not currently receiving any cancer treatment (but you can join if you're off treatment).
- Your disease shows measurable signs in your blood (or you agree to bone marrow tests if you have AML).
- You are able to care for yourself (performance status 0, 1, or 2).
- You have adequate liver and kidney function (based on blood tests).
- You do not have an active infection or severe nerve problems (like neuropathy).
- If you can become pregnant, you must have a negative pregnancy test and be willing to use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SBO-154 to see if it is safe and tolerable for people with advanced solid tumors that have not responded to standard treatments. It may be an option if you have few or no other treatment choices.
This trial tests new treatment options for people whose acute myeloid leukemia (AML) has either not responded to standard therapy or returned. It aims to find better ways to help those who need new options.
This early-phase study tests SLS009 (also called GFH009), a targeted medicine, to treat certain blood cancers—especially high-risk or difficult-to-treat AML. It’s designed to see how the drug works, how safe it is, and what dose may be best for you.
This study tests an experimental drug called S241656, either alone or with another medication, for people with certain blood cancers (AML, MDS/AML, or CMML) that haven't responded to standard treatments. The goal is to see if the drug is safe and effective in shrinking or controlling the cancer.
This study tests whether a high-fiber plant-based diet can improve gut health in people with smoldering multiple myeloma. It aims to see if diet changes can slow or prevent the disease from progressing.
This early-phase study tests a new drug called STX-0712 for people with certain types of blood cancers (CMML or AML) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink or control the cancer.
Hear when a new AML (Acute Myeloid Leukemia) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.